SMTL ID : 3l8v.1

Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor C-MET in complex with a biarylamine based inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x L8V: 2-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}amino)-N-(2,4-difluorophenyl)pyridine-3-carboxamide(Non-covalent)

L8V.1: 23 residues within 4Å: Chain A: I.38, V.46, A.62, K.64, E.81, G.82, M.85, F.88, V.93, L.94, V.109, L.111, P.112, Y.113, M.114, L.149, F.154, H.156, M.165, V.174, A.175, D.176, F.177 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:I.38, A:A.62, A:F.88, A:F.88, A:V.93, A:L.94, A:L.111, A:F.154, A:D.176, A:F.177 Hydrogen bonds: A:M.114, A:M.114, A:D.176, A:D.176

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Williams, D.K. et al., Design, synthesis and structure-activity relationships of novel biarylamine-based Met kinase inhibitors. Bioorg.Med.Chem.Lett. (2010)

Release Date

2010-05-05

Peptides

Hepatocyte growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Hepatocyte growth factor receptor

Related Entries With Identical Sequence